A comparison trial concluded that Fosamax (alendronate sodium) was more effective at maintaining or increasing bone mass density than Actonel (risedronate). Fosamax is the only FDA approved treatment for osteporosis and aims to reduce the risk of fractures in postmenopausal women. However, the drugs both had side effects at a similar rate and included: abdominal pain, diarrhea, constipation, heartburn, flatulence, nausea, vomiting, joint pain, muscle pain and headache. Fosamax is not recommended for use by people suffering gastrointestinal problems.
Source: summary of medical news story as reported by Onlypunjab
About: Comparison trial shows Fosamax to be a winner for osteoporosis treatment
Date: 15 October 2004
Source: Onlypunjab
URL:
http:/ This summary article refers to the following medical categories:
What do you think about the features of this website?
Take our user survey and have your say:
Tools & Services:
Medical Articles:
Related Medical Topics
More News Topics
» Next page: Complication of breast cancer not publicized enough
Rate This Website
Medical Tools & Articles:
Forums & Message Boards
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2010 Health Grades Inc. All rights reserved.
